-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
-
Summary
-
CNS Pharmaceuticals, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2017 to Q2 2024.
- CNS Pharmaceuticals, Inc. Stockholders' Equity Attributable to Parent for the quarter ending June 30, 2024 was -$4.29M, a 275% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)